Does CAPLACIZUMAB Cause Epistaxis? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Epistaxis have been filed in association with CAPLACIZUMAB (Cablivi). This represents 5.5% of all adverse event reports for CAPLACIZUMAB.
8
Reports of Epistaxis with CAPLACIZUMAB
5.5%
of all CAPLACIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Epistaxis From CAPLACIZUMAB?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for CAPLACIZUMAB.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Haemorrhage (9)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which CAPLACIZUMAB Alternatives Have Lower Epistaxis Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL